Search

New technology from GN Hearing addresses the No.1 hearing aid challenge: hearing speech in noise

ReSound OMNIA, the latest innovation from GN Hearing, promises to set a new standard in hearing technology.

FDA grants Lenire tinnitus treatment device De Novo approval

Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.

Choose Experience. Choose Expertise. Choose BenCorpp®

BenCorpp® is more than just a company - it is a family-owned business located in Mirandola, a small town in northern Italy, known worldwide as “the Biomedical Valley of Europe”.

New patient education infographic from Cl-ear™

According to research into the nation’s hearing health habits commissioned by Cl-ear™, the fastest growing OTC ear care range¹, DIY ear wax removal is rife.

Leading in cochlear implant reliability

All MED-EL’S titanium cochlear implants since 2006 have an overall cumulative survival rate of over 99%.

Develop your clinical skills with the Interacoustics Academy

The Interacoustics Academy supports hearing care professionals by giving access to the most current and relevant clinical knowledge in hearing and balance.

Carleton Introduce New 445nm Blue Laser

Carleton Medical are the new UK distributor for the BlueScan ENT 445nm Laser from manufacturer InterMedic.

Otovent new app launched – come and explore Otopia!

Otovent proudly launches their new fun, easy to use app to help track Otovent use.

Minimise waiting times with Peptest!

In laryngopharyngeal reflux (LPR), refluxed stomach contents travel up the oesophagus and reach the larynx, causing chronic extra-gastrointestinal symptoms such as a persistent cough, hoarseness or difficulty swallowing, meaning it is often attributed to ENT problems.

BHM-Tech takes over the Sophono product line from Medtronic

We are pleased to announce, that we have taken over the global support of the Sophono hearing system from owner Medtronic.

Peptest Q&A

Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.